Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

(2E)-5-[3-[(phenylsulfonyl)amino]phenyl]-pent-2-en-4-ynohydroxamic acid and its derivatives as novel and potent inhibitors of ras transformation.

Journal of medicinal chemistry - 19 Jul 1996

Ohtani M, Matsuura T, Shirahase K, Sugita K

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 3T3 Cells
Share to Cell Line, Transformed
Share to Cell Transformation, Neoplastic
Share to Genes, ras

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hydroxamic Acids

Share to Molecular Structure

Share to Structure-Activity Relationship

Share to Sulfonamides

Source

Identifiers

PMID: 8709119
DOI: 10.1021/jm960174k

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

(2E)-5-[3-[(phenylsulfonyl)amino]phenyl]-pent-2-en-4-ynohydroxamic acid and its derivatives as novel and potent inhibitors of ras transformation.PMID 8709119Read ↗

Identification of potent Ras signaling inhibitors by pathway-selective phenotype-based screening.Semantic proximity Read ↗

Structure-activity studies on arylamides and arysulfonamides Ras inhibitors.Semantic proximity Read ↗

Design, Synthesis, and Biological Evaluation of Levoglucosenone‐Derived Ras Activation InhibitorsSemantic proximity Read ↗

Selective cytotoxicity of a bicyclic Ras inhibitor in cancer cells expressing K-Ras(G13D).Semantic proximity Read ↗

1-Amino-4-benzylphthalazines as Orally Bioavailable Smoothened Antagonists with Antitumor ActivitySemantic proximity Read ↗

Design and synthesis of cyclic sulfonamides and sulfamates as new calcium sensing receptor agonists.Semantic proximity Read ↗

Ras proteins as therapeutic targets.Semantic proximity Read ↗

The Endeavours in RAS Inhibition - the Past, Present, and Future.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.